TW313571B - - Google Patents

Download PDF

Info

Publication number
TW313571B
TW313571B TW080105860A TW80105860A TW313571B TW 313571 B TW313571 B TW 313571B TW 080105860 A TW080105860 A TW 080105860A TW 80105860 A TW80105860 A TW 80105860A TW 313571 B TW313571 B TW 313571B
Authority
TW
Taiwan
Prior art keywords
pro
gly
val
thr
arg
Prior art date
Application number
TW080105860A
Other languages
English (en)
Chinese (zh)
Original Assignee
United Biomedical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by United Biomedical Inc filed Critical United Biomedical Inc
Application granted granted Critical
Publication of TW313571B publication Critical patent/TW313571B/zh

Links

TW080105860A 1991-06-24 1991-07-27 TW313571B (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71981991A 1991-06-24 1991-06-24

Publications (1)

Publication Number Publication Date
TW313571B true TW313571B (ja) 1997-08-21

Family

ID=51566570

Family Applications (1)

Application Number Title Priority Date Filing Date
TW080105860A TW313571B (ja) 1991-06-24 1991-07-27

Country Status (1)

Country Link
TW (1) TW313571B (ja)

Similar Documents

Publication Publication Date Title
JP2763215B2 (ja) Ｈｃｖに対する抗体の検出、ｈｃｖ感染の診断及びワクチンとしてのその予防に特異的な合成ペプチド
CA2110058C (en) Hepatitis c virus (hcv) polypeptides
AU671623B2 (en) Process for the determination of peptides corresponding to immunologically important epitopes and biotinylated peptides used therein
US5747239A (en) Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and preventions thereof as vaccines
JP2675009B2 (ja) 改良ペプチド組成物およびｈｉｖに対する抗体の検出方法
KR0185373B1 (ko) Hcv 폴리단백질에서 유래되는 hcv 아미노산 서열 부분을 포함하는 폴리펩티드 및 그 사용
Scarselli et al. Occurrence of antibodies reactive with more than one variant of the putative envelope glycoprotein (gp70) hypervariable region 1 in viremic hepatitis C virus-infected patients
WO1995011998A1 (en) Structured synthetic antigen libraries as diagnostics, vaccines and therapeutics
EP0489968A1 (en) Synthetic antigens for the detection of antibodies to hepatitis C virus
NZ266148A (en) Polynucleic acid compositions of hepatitis c virus sequences, hcv protein compositions and uses of both
CZ294629B6 (cs) Způsob klasifikace typů hepatitis C viru, polypeptid a kompozice pro použití ve způsobu
Cerino et al. Identification of an immunodominant B cell epitope on the hepatitis C virus nonstructural region defined by human monoclonal antibodies.
US5582968A (en) Branched hybrid and cluster peptides effective in diagnosing and detecting non-A, non-B hepatitis
US5639594A (en) Linear and branched peptides effective in diagnosing and detecting non-A, non-B hepatitis
TW313571B (ja)
US6667387B1 (en) HCV core peptides
Chang et al. Antigenic heterogeneity of the hepatitis C virus NS4 protein as modeled with synthetic peptides
WO1991006562A1 (en) Immunological domains of hepatitis delta virus antigen
Chang et al. Artificial NS4 mosaic antigen of hepatitis C virus
US6709828B1 (en) Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
AU649473B2 (en) Enterovirus peptides
AU671594C (en) Hepatitis C virus (HCV) polypeptides
Huang et al. Identification of immunodominant, group-specific and subcomplex-specific, continuous epitopes in the core regions of Japanese encephalitis virus using synthetic peptides
KR100187483B1 (ko) Hcv 폴리뉴클레오티드 및 그 사용
AU2007200847A1 (en) Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes and methods for their use